Literature DB >> 28502088

Limited impact of awareness-raising campaigns on hepatitis C testing practices among general practitioners.

A McLeod1, B L Cullen1, S J Hutchinson1,2, K M Roy1, J F Dillon3, E A Stewart4, D J Goldberg1.   

Abstract

The global hepatitis strategy calls for increased effort to diagnose those infected, with a target of 90% diagnosed by 2030. Scotland's Action Plan on Hepatitis C included awareness-raising campaigns, undertaken during 2008-2011, to promote testing by general practitioners. We examined hepatitis C virus (HCV) testing practice among general practitioners before and following these campaigns. Scottish general practitioners were surveyed, using Dillman's method, in 2007 and 2013; response rates were 69% and 60%, respectively. Most respondents offer testing when presented with a risk history (86% in 2007, 88% in 2013) but only one-fifth actively sought out risk factors (19% in 2007, 21% in 2013). Testing was reportedly always/almost always/usually offered to people who inject drugs (84% in 2007, 87% in 2013). Significant improvements in the offer of testing were reported in patients with abnormal LFTs (41% in 2007, 65% in 2013, P<.001) and who had received medical/dental treatment in high prevalence countries (14% in 2007, 24% in 2013, P=.001). In 2013, 25% of respondents had undertaken HCV-related continued professional development. This group was significantly more likely to actively seek out risk factors (P=.009) but only significantly more likely to offer a test to patients who had received medical/dental treatment in high prevalence countries (P=.001). Our findings suggest that government-led awareness raising campaigns have limited impact on general practitioners' testing practices. If the majority of the HCV-infected population are to be diagnosed, practitioner-based or physician-centred interventions should be considered alongside educational initiatives targeted at professionals.
© 2017 John Wiley & Sons Ltd.

Entities:  

Keywords:  awareness raising; general practice; hepatitis C; survey; testing

Mesh:

Year:  2017        PMID: 28502088     DOI: 10.1111/jvh.12724

Source DB:  PubMed          Journal:  J Viral Hepat        ISSN: 1352-0504            Impact factor:   3.728


  6 in total

1.  A survey of knowledge, attitudes, barriers and support needs in providing hepatitis B care among GPs practising in Australia.

Authors:  Yinzong Xiao; Caroline van Gemert; Jess Howell; Jack Wallace; Jacqueline Richmond; Emily Adamson; Alexander Thompson; Margaret Hellard
Journal:  BMC Prim Care       Date:  2022-06-02

2.  Awareness and knowledge of hepatitis C among health care providers and the public: A scoping review.

Authors:  S Ha; K Timmerman
Journal:  Can Commun Dis Rep       Date:  2018-07-05

3.  Barriers to and facilitators of hepatitis C virus screening and testing: A scoping review.

Authors:  N Shehata; T Austin; S Ha; K Timmerman
Journal:  Can Commun Dis Rep       Date:  2018-07-05

4.  Retrospective Evaluation of Hepatitis C Awareness in Turkey Through Two Decades.

Authors:  Hatice Yasemin Balaban; Osman Dağ; Alparslan Alp; Nomingerel Tseveldorj; Cavanşir Vahabov; Mehmet Akif Göktaş; Tuğrul Pürnak; Gülşen Hasçelik; Hülya Demir; Bülent Sivri; Halis Şimşek
Journal:  Turk J Gastroenterol       Date:  2021-01       Impact factor: 1.852

Review 5.  Innovative strategies for the elimination of viral hepatitis at a national level: A country case series.

Authors:  Sophia E Schröeder; Alisa Pedrana; Nick Scott; David Wilson; Christian Kuschel; Lisa Aufegger; Rifat Atun; Ricardo Baptista-Leite; Maia Butsashvili; Manal El-Sayed; Aneley Getahun; Saeed Hamid; Radi Hammad; Ellen 't Hoen; Sharon J Hutchinson; Jeffrey V Lazarus; Olufunmilayo Lesi; Wangsheng Li; Rosmawati Binti Mohamed; Sigurdur Olafsson; Raquel Peck; Annette H Sohn; Mark Sonderup; Catherine W Spearman; Tracy Swan; Mark Thursz; Tim Walker; Margaret Hellard; Jessica Howell
Journal:  Liver Int       Date:  2019-09-04       Impact factor: 5.828

6.  Liver function tests in primary care provide a key opportunity to diagnose and engage patients with hepatitis C.

Authors:  A McLeod; S J Hutchinson; A Weir; S Barclay; J Schofield; C Gillespie Frew; D J Goldberg; M Heydtmann; E Wilson-Davies
Journal:  Epidemiol Infect       Date:  2022-06-27       Impact factor: 4.434

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.